Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $375.8b | $143.85 | -0.2% | 1.2K |
 GILD | Gilead Sciences Inc | $185.5b | $146.16 | 0.0% | 748 |
 PFE | Pfizer Inc. | $164.2b | $27.57 | +0.1% | 10.5K |
 MRNA | Moderna, Inc. Common Stock | $59.4b | $144.49 | 0.0% | 36.8K |
 SMMT | Summit Therapeutics Inc. Common Stock | $13.7b | $17.40 | 0.0% | 6.6K |
 PCVX | Vaxcyte, Inc. Common Stock | $9.1b | $59.20 | 0.0% | N/A |
 BCRX | BioCryst Pharmaceuticals Inc | $2.6b | $8.31 | 0.0% | 328 |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.9b | $10.45 | 0.0% | 5 |
 NVAX | Novavax Inc | $1.7b | $9.22 | 0.0% | 4.5K |
 ABUS | Arbutus Biopharma Corporation Common Stock | $1.0b | $5.22 | 0.0% | 16 |
 ASMB | Assembly Biosciences, Inc | $0.7b | $27.03 | 0.0% | 306 |
 CRMD | CorMedix Inc. | $0.7b | $7.75 | 0.0% | 316 |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $475.8m | $14.79 | 0.0% | 2.3K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $457.2m | $5.23 | 0.0% | N/A |
 ENTA | Enanta Pharmaceuticals, Inc | $410.4m | $12.30 | 0.0% | N/A |
 EBS | Emergent Biosolutions, Inc. | $331.2m | $6.25 | 0.0% | N/A |
 IVVD | Invivyd, Inc. Common Stock | $237.0m | $0.80 | 0.0% | 41.7K |
 SIGA | SIGA Technologies Inc. | $232.1m | $2.97 | 0.0% | N/A |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $229.3m | $12.45 | 0.0% | 342 |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $224.5m | $5.35 | 0.0% | N/A |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $205.6m | $4.33 | -2.1% | 2.7K |
 INO | Inovio Pharmaceuticals, Inc. | $140.6m | $1.17 | 0.0% | 421 |
 ZTEK | Zentek Ltd. Common Stock | $85.3m | $0.49 | 0.0% | N/A |
 SPRO | Spero Therapeutics, Inc. Common Stock | $71.0m | $1.11 | 0.0% | N/A |
 XBIT | XBiotech Inc | $67.1m | $2.19 | 0.0% | N/A |
 MCRB | Seres Therapeutics, Inc. | $56.7m | $4.59 | 0.0% | 5 |
 SCYX | SCYNEXIS, Inc. | $53.2m | $4.49 | 0.0% | N/A |
 IBO | Impact BioMedical, Inc. | $52.8m | $0.56 | +0.0% | 1.6K |
 TVGN | Tevogen Inc. Common Stock | $46.7m | $7.76 | 0.0% | N/A |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $38.8m | $5.04 | 0.0% | N/A |
 NNVC | NanoViricides Inc. | $29.4m | $1.09 | 0.0% | 127 |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $26.2m | $10.95 | 0.0% | N/A |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $24.5m | $2.37 | 0.0% | 7 |
 COCP | Cocrystal Pharma, Inc. Common Stock | $22.3m | $1.15 | 0.0% | N/A |
 MBRX | Moleculin Biotech, Inc. | $13.2m | $0.78 | 0.0% | 62 |
 XBIO | Xenetic Biosciences, Inc. | $10.8m | $4.21 | 0.0% | 6 |
 IMNN | Imunon, Inc. Common Stock | $8.8m | $1.47 | 0.0% | 103 |
 SNGX | Soligenix, Inc. Common Stock | $8.3m | $0.36 | 0.0% | 5.6K |
 TRAW | Traws Pharma, Inc. Common Stock | $8.3m | $0.53 | 0.0% | 1 |
 CODX | Co-Diagnostics, Inc. Common Stock | $8.1m | $1.13 | 0.0% | 4.1K |
 AIM | AIM ImmunoTech Inc. | $7.1m | $0.21 | -1.7% | 291.1K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.4m | $0.80 | 0.0% | N/A |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $6.1m | $1.42 | 0.0% | 73 |
 SBFM | Sunshine Biopharma Inc. | $4.3m | $1.03 | 0.0% | 24 |
 PHGE | BiomX Inc. | $3.8m | $1.88 | 0.0% | N/A |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $3.3m | $0.86 | 0.0% | 72 |
 GOVX | GeoVax Labs, Inc. New | $2.9m | $0.41 | 0.0% | 3.4K |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $2.0m | $2.55 | 0.0% | 919 |
 AEMD | AETHLON MEDICAL INC | $1.3m | $1.44 | 0.0% | 560 |